Dr Hernández-Boluda on an EBMT Machine Learning Model for Identifying and Stratifying Transplant Risk in Myelofibrosis

Juan Carlos Hernández-Boluda, MD, PhD, an associated physician at the Hematology and Medical Oncology Service of the Hospital Clínico of Valencia, discusses an EBMT machine learning–based model for identifying and stratifying transplant risk for patients with myelofibrosis.